Brian J. Groat, MD, Helga P. Sandoval, MD, MSCR, Mohamed A. Guenena, MD, Kerry D. Solomon, MD

Magill Research Center for Vision Correction, Storm Eye InstituteMedical University of South Carolina, Charleston, SC

Financial DisclosureFinancial DisclosureBrian J. Groat & Mohamed A. Guenena: NoneBrian J. Groat & Mohamed A. Guenena: NoneHelga P. Sandoval: Alcon Laboratories, Inc. - D; Allergan, Inc. - D; Abbott Medical Optics - DHelga P. Sandoval: Alcon Laboratories, Inc. - D; Allergan, Inc. - D; Abbott Medical Optics - DKerry D. Solomon: Alcon Laboratories, Inc. - A,C,D; Allergan, Inc. - A,C,D; Abbott Medical Optics - A,C,D; Kerry D. Solomon: Alcon Laboratories, Inc. - A,C,D; Allergan, Inc. - A,C,D; Abbott Medical Optics - A,C,D; Advanced Vision Research - A,C,D; Bausch & Lomb, Inc. - A,C,D; Eyemaginations - A,C,D; QLT, Inc. - A,C,D Advanced Vision Research - A,C,D; Bausch & Lomb, Inc. - A,C,D; Eyemaginations - A,C,D; QLT, Inc. - A,C,D

– AcrySof Single-Piece platform– Open loop, modified-L haptics– Posterior toricity – Toric axis marks

AcrySof Toric AcrySof Toric

IOL ModelIOL Model

Cylinder Power @Cylinder Power @

IOL PlaneIOL Plane Corneal PlaneCorneal Plane

SN60T3SN60T3 1.501.50 1.031.03

SN60T4SN60T4 2.252.25 1.551.55

SN60T5SN60T5 3.003.00 2.062.06

To report visual outcomes of astigmatic patients implanted with a toric IOL

To compare their satisfaction and spectacle freedom to a standard monofocal IOL group

Inclusion Criteria Uneventful routine lens

extraction between Aug 06 and Aug 08

IOL Implanted› Toric (Acrysof Toric IOL,

SN60T3)› Monofocal (Acrysof IQ,

SN60WF) Follow-up at least 3 weeks

post-surgery

Exclusion Criteria Keratorefractive surgery before

or after lens extraction and IOL implantation

Any pre or postoperative pathology that could affect visual outcome

Any postoperative complication Monovision Other ocular surgery at the

time of the cataract extraction

• Retrospective chart review

• IOL groups were age, gender, preoperative manifest cylinder, manual cylinder and topographic cylinder matched for comparison

Uncorrected visual acuity

Residual astigmatism

Patient satisfaction and spectacle freedom survey› Bilateral implantation of the same IOL

A total of 547 medical records were reviewed

104 eyes of 80 subjects met inclusion/exclusion criteria and were included for analysis

ToricToricn = 62 eyesn = 62 eyes

MonofocalMonofocaln = 42 eyesn = 42 eyes P P value† value†

Age (years)Age (years) 73.8 ± 8.473.8 ± 8.4 71.9 ±9.771.9 ±9.7 .302.302

GenderGender 64.5% F64.5% F 50.0% F50.0% F .140*.140*

Sph (D)Sph (D) -2.0 ± 3.2-2.0 ± 3.2 -1.0 ± 3.3-1.0 ± 3.3 .057.057

Cyl (D)Cyl (D) 1.2 ± 0.81.2 ± 0.8 1.3 ± 0.91.3 ± 0.9 .930.930

SE (D)SE (D) -1.4 ± 3.3-1.4 ± 3.3 -0.4 ± 3.2-0.4 ± 3.2 .069.069

Manual Cyl (D)Manual Cyl (D) 1.1 ± 0.31.1 ± 0.3 1.3 ± 0.71.3 ± 0.7 .548.548

Topo Astigm (D)Topo Astigm (D) 1.2 ± 0.41.2 ± 0.4 1.5 ± 0.71.5 ± 0.7 .276.276

† † Wilcoxon testWilcoxon test* Fisher’s Exact test* Fisher’s Exact test

Cylin

der

(Dio

pte

rs)

UCVA in the toric IOL group was as good as the BCVA in the monofocal IOL group.

Although sample size of subjects who answer the survey is small there is a trend that shows higher satisfaction in the toric group.

Toric IOL is an alternative to patients who wants distance spectacle independence.